Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical ApplicationsIzabela Zakrocka, Waldemar A. Turski, Katarzyna M. Targowska‐Duda et al.|Neurotoxicity Research|2017Cited by 36
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive ratsBożena Bądzyńska, Elżbieta Kompanowska‐Jezierska, Izabela Zakrocka et al.|European Journal of Pharmacology|2014Cited by 26
Kynurenic acid selectively reduces heart rate in spontaneously hypertensive ratsBożena Bądzyńska, Elżbieta Kompanowska‐Jezierska, Izabela Zakrocka et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2019Cited by 18
Binge-like mephedrone treatment induces memory impairment concomitant with brain kynurenic acid reduction in miceMarta Marszałek‐Grabska, Waldemar A. Turski, Jolanta H. Kotlińska et al.|Toxicology and Applied Pharmacology|2022Cited by 14
Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in VitroIzabela Zakrocka, Waldemar A. Turski, Katarzyna M. Targowska‐Duda et al.|Neurotoxicity Research|2018Cited by 12